What’s new at SeqOne?
New platform features, customer success stories, awards and other great news about SeqOne…. you’ll find it all here. Journalists, we have a dedicated page for you.
-
Events News7 September 2021
ESHG 2021 Conference – Satellite symposium replay
With @Eurofins Biomnis, SeqOne recently held a symposium on CNV detection in exome data, performance comparisons with traditional method and the clinical impact of fast [...]
-
Events News30 June 2021
AMP 2021 – Learn more about SeqOne and its somatic platform
Learn more about SeqOne and its somatic platform that can analyze small or large pan-cancer DNA/RNA panels and TMB, MSI, HRD signature for the therapeutic [...]
-
News
22 March 2021
Myriam Guiral, the new SeqOne CCO EMEA & Biopharma Head
We are very pleased to announce the appointment of Myriam Guiral to the role of CCO EMEA & Biopharma Head. Myriam has more than 20 years of [...]
-
News
18 January 2021
Using molecular clocks to tell cancer time
We all know tracking metastatic cancer progression is vital for ongoing monitoring of cancer patients, but how do metastatic cancers arise in the first place? [...]
-
Platform features
3 December 2020
Detect fusion genes with SeqOne!
https://youtu.be/eYfj7JlKc4k RNAseq analysis is now possible using the SeqOne Platform so that you can include the detection of expressed SNVs, Indels and fusion genes in [...]
-
Platform features Science
14 May 2020
Mobile element insertion (MEI) detection for NGS based clinical diagnostics
A growing number of scientific articles describe the pathogenic role of MEI’s, bringing a renewed focus on their importance in clinical diagnosis. Although NGS makes [...]
-
News Press release
1 May 2020
A French start-up harnesses the power of the latest generation genomic sequencers to dramatically increase COVID 19 testing capacity
SeqOne Genomics, a start-up specialized in genomic analysis software, is partnering with leading medical testing labs to develop an approach that delivers up to 100 [...]
-
Platform features Science
31 March 2020
Challenges and importance of mid-sized deletion identification for genomic medicine
The clinical importance of mid-sized deletions is becoming increasingly apparent with a growing number of variants of this type being identified as pathogenic in the [...]
-
News Press release
30 January 2020
EUROFINS BIOMNIS AND SEQONE PARTNER TO IMPROVE CLINICAL ACCESS TO WHOLE EXOME TESTING
Eighty percent of rare diseases are genetic in origin and result from a small number of genetic mutations. Identifying these variations is essential in diagnosing [...]
-
BioTech News
28 February 2018
Canadian and French startups announce genomics partnership to better diagnose rare disease
February 28th, 2018: Paris, France & Toronto, Canada Gene42 Inc., a Toronto company that develops software for precision medicine, and SeqOne, a French life [...]
-
News Press release
1 October 2017
SeqOne wins prestigious iLab grant to improve genomics analysis software in healthcare
Montpellier 12th of July, 2017: SeqOne a French start-up in the genomic medicine market is proud to announce that it has been awarded an i-Lab [...]
